Check Palexia strips: TGA

A labelling problem has seen Seqirus undertake a product defect correction over one batch of Palexia The TGA has advised consumers and health professionals that in consultation with the TGA, the company has undertaken a product defect correction involving a batch of Palexia 100mg sustained-release (SR) tapentadol tablets due to a labelling fault. “Some packages